Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Genaera Corporation is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. Research and development efforts are focused on anti-angiogenesis and respiratory diseases. Genaera has three products in development addressing substantial unmet medical needs in major pharmaceutical markets. These include squalamine, an anti-angiogenesis treatment for cancer and eye disease; interleukin-9 antibody, a respiratory treatment based on the discovery of a genetic cause of asthma; and LOMUCINÔ, a mucoregulator to treat the overproduction of mucus and secretions involved in many forms of chronic respiratory disease. ( www.genaera.com )
Genaera Corporation
5110 Campus Drive
Plymouth Meeting, Pennsylvania 19462
USA
Tel: (610) 941-4020
Fax: (610) 941-5399